Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

ClinicalTrials.gov

A Study to Evaluate Safety and Efficacy of Selinexor in Combination With Ruxolitinib in Participants With Myelofibrosis - Full Text View.

  • 123456 Profile photo of Madelyn

    This is a promising phase I study combining ruxolitinib and selinexor for frontline therapy of myelofibrosis. So far 15 patients were dosed with acceptable toxicities and the initial data is presented in poster format at #ASCO22.